Hydrochloric Acid → (S)-3-(4-(3-(4-Trifluoromethylphenylsulfonamido)benzyloxy)-phenyl)-3-(isoxazol-3-yl)propanoic acid
反応式
C([C@H]1COC(=O)N1C(=O)[CH2:15][C@@H:16]([C:22]1[CH:49]=[CH:48][C:25]([O:26][CH2:27][C:28]2[CH:29]=[C:30]([NH:34][S:35]([C:38]3[CH:43]=[CH:42][C:41]([C:44]([F:47])([F:46])[F:45])=[CH:40][CH:39]=3)(=[O:37])=[O:36])[CH:31]=[CH:32][CH:33]=2)=[CH:24][CH:23]=1)[C:17]1[CH:21]=[CH:20][O:19][N:18]=1)C1C=CC=CC=1.[OH:51]O.[Li+].[OH-].Cl.C1[CH2:60][O:59]CC1>O>[F:46][C:44]([F:45])([F:47])[C:41]1[CH:40]=[CH:39][C:38]([S:35]([NH:34][C:30]2[CH:29]=[C:28]([CH:33]=[CH:32][CH:31]=2)[CH2:27][O:26][C:25]2[CH:48]=[CH:49][C:22]([C@@H:16]([C:17]3[CH:21]=[CH:20][O:19][N:18]=3)[CH2:15][C:60]([OH:59])=[O:51])=[CH:23][CH:24]=2)(=[O:37])=[O:36])=[CH:43][CH:42]=1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of the oxazolidinone (32.1) (17.0 mg, 0.0241 mmol) dissolved in THF (2 mL), was added a 30% hydrogen peroxide solution (27.0 μL, 0.241 mmol) followed by a 2 M LiOH solution (60.0 μL, 0.121 mmol). The resulting slurry was stirred for one hour. The reaction mixture was then diluted with water and acidified with hydrochloric acid to pH 3. The mixture was then extracted with EtOAc (1×20 mL), and the organic layer was washed with an acidic sodium sulfite solution (2×15 mL) and brine (1×15 mL), and dried over magnesium sulfate. The filtrate was concentrated under reduced pressure, and the residue was purified by reverse phase HPLC to give 32 (6.00 mg). MS ESI (pos.) m/e: 547.0 (M+H). 1H NMR (400 MHz, CD3CN) δ ppm 8.32 (1 H, d, J=1.6 Hz), 7.81 (2 H, d, J=8.2 Hz), 7.69 (2 H, d, J=8.2 Hz), 7.04-7.23 (5 H, m), 6.95 (1 H, d, J=7.8 Hz), 6.79 (2 H, d, J=9.0 Hz), 6.15 (1 H, d, J=1.6 Hz), 4.91 (2 H, s), 4.44 (1 H, t, J=7.8 Hz), 3.08 (1H, dd, J=16.4, 8.2 Hz), 2.83 (1 H, dd, J=16.4, 7.4 Hz). 6.28 Example 33
後処理
- extractionThe mixture was then extracted with EtOAc (1×20 mL)
- washthe organic layer was washed with an acidic sodium sulfite solution (2×15 mL) and brine (1×15 mL)
- dry with materialdried over magnesium sulfate
- concentrationThe filtrate was concentrated under reduced pressure
- customthe residue was purified by reverse phase HPLC
出典と根拠
- ORDレコード
- ord-0406adc923d44deebcaab8ddd4d91665
- 出典データセット
- uspto-grants-2011_08
- 特許番号
- US08003648B2
反応ノート
読み込み中…